Publications

Read our policy on the COVID-19 Vaccine Claims Scheme. It sets out the rules that govern the scheme.

This report on Key Performance Measures for the Seventh Community Pharmacy (7CPA) covers the periods: 1 July – 31 December 2022, 1 January – 30 June 2023 and 1 July- 31 December 2023.

This report on key performance measures for the Seventh Community Pharmacy (7CPA) covers the periods: 1 January – 30 June 2022, 1 July – 31 December 2022 and 1 January – 30 June 2023.

This document sets out points to consider for doctors providing clinical opinion in support of COVID-19 vaccine injury claims following vaccination with a TGA approved vaccine.

This document sets out points to consider for doctors providing clinical opinion in support of COVID-19 vaccine injury claims following vaccination with a TGA approved vaccine.

This report on key performance measures for the Seventh Community Pharmacy (7CPA) covers the periods: 1 July – 31 December 2021, 1 January – 30 June 2022, 1 July – 31 December 2022.

This report on key performance measures for the Seventh Community Pharmacy (7CPA) covers the periods: 1 January – 30 June 2021, 1 July – 31 December 2021 and 1 January – 30 June 2022.

This report on key performance measures for the Seventh Community Pharmacy Agreement (7CPA) covers the first three six-month reporting periods: 1 July – 31 December 2020, 1 January – 30 June 2021 and 1 July – 31 December 2021.

This document contains approved key performance measures and monitoring arrangements for the Seventh Community Pharmacy Agreement (7CPA).

This document explains how the measures for the Seventh Community Pharmacy Agreement (7CPA) are developed and monitored.